This fusion leads to aberrant activation of ROS1 tyrosine kinase, rendering patients highly susceptible to ROS1 inhibitors.[40] LAMP3 is involved in the autophagic process and has been shown to contribute to tamoxifen resistance in breast cancer. The gene discussed is ROS1; the disease is breast cancer.